Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 32Recruiting 18Terminated 12Active not recruiting 11Unknown 4Withdrawn 3Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Nivolumab 2Docetaxel 2tivozanib 1gallium 68 PSMA-11 1atezolizumab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Specimen Handling 1Paclitaxel 1Oxycodone 1Menogaril 1Magnetic Resonance Imaging 1Ketorolac 1Ketamine 1Interleukin-2 1Genome 1Genetic Testing 1Etoposide 1Cisplatin 1Carboplatin 1CYT003-QbG10 1Biopsy 1Acetaminophen 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × abiraterone × Clear all
NCT05361915 2024-03-18

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Sorrento Therapeutics, Inc.

Phase 2 Suspended
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡